Banco Santander (SAN) amends 13F after confidential treatment expires; $1.10M reported
Filing Impact
Filing Sentiment
Form Type
13F-HR/A
Rhea-AI Filing Summary
Banco Santander, S.A. filed an amended Form 13F disclosing holdings reported originally on Form 13F filed 08-01-2025 with confidential treatment that expired on 03-04-2026. The amendment adds new holdings entries and the report lists 1 information table entry with a total value of $1,103,613.
Positive
- None.
Negative
- None.
FAQ
What does Banco Santander's (SAN) 13F amendment disclose?
The amendment adds new holdings entries and restates certain items. It references the Form 13F filed on 08-01-2025 and notes confidential treatment expired on 03-04-2026, with the filing signed on 03-05-2026.
How many holdings and what total value are reported by SAN in this 13F amendment?
The amended Form 13F shows 1 information table entry and a total reported value of $1,103,613. This figure is the summed value reported on the Form 13F information table within the filing.
Who signed Banco Santander's 13F amendment and when was it signed?
The report is signed by Ruben Navajo, Head of Group Accounting. The signature block shows the filing was signed in Madrid on 03-05-2026 under the reporting manager's authorization.
What does the expired confidential treatment mean in SAN's filing?
Confidential treatment covered holdings reported on the Form 13F filed 08-01-2025 and expired on 03-04-2026. The amendment discloses those previously confidential entries following the expiration per the filing's statement.
Does the 13F amendment indicate multiple managers or included managers for SAN?
The Form 13F summary lists 0 other included managers and explicitly states NONE for a list of other included managers, indicating this report covers the reporting manager's holdings only.